$1.165
-0.053 (-4.51%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
MEDS Prediction & Forecast by Similar Chart Analysis
Alphio's MEDS stock price prediction model matches the current Scienture Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.14 (-2.07%). The 1-week path is $1.12 (-3.78%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Scienture Holdings Inc Stock?
TRxADE Health Inc (MEDS) is not a good buy right now due to significant financial losses and poor technical indicators. The current price is $1.17, with a 5-day change of -39.32% and a year-to-date change of -66.90%. The RSI is at 9.228, indicating that the stock is extremely oversold, but this does not guarantee a rebound. The main risk is the company's negative net income, which reached -$18,363,225 in Q2 2026, reflecting ongoing financial instability.
MEDS stock price ended at $1.17 on Friday, after losing -4.51%
Scienture Holdings Inc (MEDS) last closed at $1.165, losing -4.51%. These facts feed the 1-day and 1-week MEDS price prediction above.
Forecast Drivers
Scienture Holdings Inc (MEDS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches MEDS, ranked by similarity.
Seasonality analysis for MEDS
Related articles
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.